Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
12.35
-0.18 (-1.44%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Avanos Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | Upgrade
|
| Cash & Short-Term Investments | 107.7 | 87.7 | 127.7 | 118.5 | 111.5 | Upgrade
|
| Cash Growth | 22.80% | -31.32% | 7.76% | 6.28% | -45.69% | Upgrade
|
| Accounts Receivable | 127.9 | 128.7 | 155.7 | 118.2 | 108.6 | Upgrade
|
| Other Receivables | 4.9 | 14.1 | 12.2 | 13 | 59.3 | Upgrade
|
| Receivables | 132.8 | 142.8 | 167.9 | 131.2 | 167.9 | Upgrade
|
| Inventory | 138.8 | 163.2 | 132.3 | 159.3 | 168.9 | Upgrade
|
| Prepaid Expenses | 14.1 | 28.8 | 13.9 | 18.6 | 18.9 | Upgrade
|
| Other Current Assets | - | 64.5 | 182.3 | - | - | Upgrade
|
| Total Current Assets | 393.4 | 487 | 624.1 | 427.6 | 467.2 | Upgrade
|
| Property, Plant & Equipment | 144.8 | 144 | 146.1 | 206.7 | 223.6 | Upgrade
|
| Goodwill | 455.6 | 796.1 | 760.3 | 801.6 | 802.5 | Upgrade
|
| Other Intangible Assets | 112.3 | 239.5 | 234.2 | 141.2 | 157.7 | Upgrade
|
| Long-Term Deferred Tax Assets | 24.9 | 6.5 | 4.6 | 10 | 10 | Upgrade
|
| Other Long-Term Assets | 23.2 | 19.3 | 17.6 | 16.5 | 11.8 | Upgrade
|
| Total Assets | 1,154 | 1,692 | 1,787 | 1,604 | 1,673 | Upgrade
|
| Accounts Payable | 54.3 | 56.3 | 67.9 | 56.4 | 67.6 | Upgrade
|
| Accrued Expenses | 73.3 | 76.5 | 76.6 | 65.1 | 80.5 | Upgrade
|
| Current Portion of Long-Term Debt | 9.4 | 8.6 | 6.2 | - | - | Upgrade
|
| Current Portion of Leases | 10.9 | 12.8 | 12 | 14.7 | 15.5 | Upgrade
|
| Current Income Taxes Payable | 18 | 16.7 | 21.2 | 3 | 2.7 | Upgrade
|
| Other Current Liabilities | - | 63.7 | 7.1 | - | - | Upgrade
|
| Total Current Liabilities | 165.9 | 234.6 | 191 | 139.2 | 166.3 | Upgrade
|
| Long-Term Debt | 125.3 | 159.4 | 226.3 | 130 | 180 | Upgrade
|
| Long-Term Leases | 24.6 | 28.3 | 32.5 | 42.8 | 53.3 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 5.5 | 23.8 | 25.4 | 11.9 | 5.7 | Upgrade
|
| Other Long-Term Liabilities | 4.4 | 10 | 20.5 | 9.1 | 11 | Upgrade
|
| Total Liabilities | 325.7 | 456.1 | 495.7 | 333 | 416.3 | Upgrade
|
| Common Stock | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | Upgrade
|
| Additional Paid-In Capital | 1,679 | 1,664 | 1,646 | 1,629 | 1,609 | Upgrade
|
| Retained Earnings | -707 | -314.9 | -253.1 | -303.6 | -315.5 | Upgrade
|
| Treasury Stock | -99 | -85.9 | -66.8 | -21.3 | -9.8 | Upgrade
|
| Comprehensive Income & Other | -44.6 | -27 | -35.8 | -33.8 | -28.1 | Upgrade
|
| Shareholders' Equity | 828.5 | 1,236 | 1,291 | 1,271 | 1,257 | Upgrade
|
| Total Liabilities & Equity | 1,154 | 1,692 | 1,787 | 1,604 | 1,673 | Upgrade
|
| Total Debt | 170.2 | 209.1 | 277 | 187.5 | 248.8 | Upgrade
|
| Net Cash (Debt) | -62.5 | -121.4 | -149.3 | -69 | -137.3 | Upgrade
|
| Net Cash Per Share | -1.36 | -2.61 | -3.16 | -1.42 | -2.87 | Upgrade
|
| Filing Date Shares Outstanding | 46 | 43.16 | 46.6 | 47.32 | 47.97 | Upgrade
|
| Total Common Shares Outstanding | 45.96 | 43.13 | 44.4 | 47.63 | 47.69 | Upgrade
|
| Working Capital | 227.5 | 252.4 | 433.1 | 288.4 | 300.9 | Upgrade
|
| Book Value Per Share | 18.03 | 28.66 | 29.08 | 26.68 | 26.35 | Upgrade
|
| Tangible Book Value | 260.6 | 200.7 | 296.7 | 327.8 | 296.3 | Upgrade
|
| Tangible Book Value Per Share | 5.67 | 4.65 | 6.68 | 6.88 | 6.21 | Upgrade
|
| Land | 1.1 | 1.3 | 1.1 | 1.1 | 1.1 | Upgrade
|
| Buildings | 40.6 | 38 | 37.2 | 48 | 46.8 | Upgrade
|
| Machinery | 186.3 | 182.8 | 168.7 | 223.2 | 218.2 | Upgrade
|
| Construction In Progress | 21.4 | 18 | 16.4 | 32 | 23.3 | Upgrade
|
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.